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Abstract
Objective To compare the performance of two new approaches to risk
adjustment that are free of the influence of observational intensity with
methods that depend on diagnoses listed in administrative databases.
Setting Administrative data from the US Medicare program for services
provided in 2007 among 306 US hospital referral regions.
Design Cross sectional analysis.
Participants 20% sample of fee for service Medicare beneficiaries
residing in one of 306 hospital referral regions in the United States in
2007 (n=5 153 877).
Main outcome measures The effect of health risk adjustment on age,
sex, and race adjusted mortality and spending rates among hospital
referral regions using four indices: the standard Centers for Medicare
and Medicaid Services—Hierarchical Condition Categories (HCC) index
used by the US Medicare program (calculated from diagnoses listed in
Medicare’s administrative database); a visit corrected HCC index (to
reduce the effects of observational intensity on frequency of diagnoses);
a poverty index (based on US census); and a population health index
(calculated using data on incidence of hip fractures and strokes, and
responses from a population based annual survey of health from the
Centers for Disease Control and Prevention).
Results Estimated variation in age, sex, and race adjusted mortality
rates across hospital referral regions was reduced using the indices
based on population health, poverty, and visit corrected HCC, but
increased using the standard HCC index. Most of the residual variation
in age, sex, and race adjusted mortality was explained (in terms of
weighted R2) by the population health index: R2=0.65. The other indices
explained less: R2=0.20 for the visit corrected HCC index; 0.19 for the
poverty index, and 0.02 for the standard HCC index. The residual
variation in age, sex, race, and price adjusted spending per capita across
the 306 hospital referral regions explained by the indices (in terms of
weighted R2) were 0.50 for the standard HCC index, 0.21 for the
population health index, 0.12 for the poverty index, and 0.07 for the visit
corrected HCC index, implying that only a modest amount of the variation
in spending can be explained by factors most closely related to mortality.
Further, once the HCC index is visit corrected it accounts for almost
none of the residual variation in age, sex, and race adjusted spending.
Correspondence to: D E Wennberg David.E.Wennberg@Dartmouth.edu
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ConclusionHealth risk adjustment using either the poverty index or the
population health index performed substantially better in terms of
explaining actual mortality than the indices that relied on diagnoses from
administrative databases; the population health index explained the
majority of residual variation in age, sex, and race adjusted mortality.
Owing to the influence of observational intensity on diagnoses from
administrative databases, the standard HCC index over-adjusts for
regional differences in spending. Research to improve health risk
adjustment methods should focus on developing measures of risk that
do not depend on observation influenced diagnoses recorded in
administrative databases.
Introduction
Per capita medical spending and utilization varies extensively
among healthcare regions, as reported in the Dartmouth Atlas
of Healthcare, the NHS Atlas of Variation, and the Spanish
Atlas of Variability.1-3 These variations have raised major
concerns about the effectiveness and equitable distribution of
healthcare services, and led naturally to an important question:
“To what extent can variations be explained by differences in
illness of the regions’ populations?”4-13
When the distribution of illness differs substantially from region
to region, risk adjustment can allow an “apples to apples”
comparison of spending and utilization. The traditional approach
to risk adjustment is to remove statistically the variation in
illness associated with age and sex. This makes intuitive sense
and fits the data: the relation between growing older and
increased illness is incontrovertible and there are conditions
(childbirth) or illnesses (prostate cancer) that only occur in one
sex. The development and use of accurate risk adjustment is
more than an academic exercise. In the United States, risk
adjustment is fundamental to healthcare reform initiated by the
Affordable Care Act.14 15 Risk adjustment is central to the
formulas used to allocate resources within the English National
Health Service and to risk equalization between competing
insurers in the Netherlands.16-18
With the advent of modern computers and “big data” transaction
files such as the USMedicare administrative and NHS hospital
episode statistics databases, new methods of adjusting for
variation in illness among population groups have been
developed using the International Classification of Diseases
(ICD) diagnosis codes recorded in these administrative
databases.18 19 Each system accomplishes risk adjustment in
roughly the same manner: a comorbidity score is developed for
each individual in the database and then used statistically to
adjust spending, mortality, and utilization rates for illness.
Certain methods have become standard in the United States for
developing comorbidity scores. The Iezzoni chronic condition
count and the Charlson comorbidity index were developed
primarily to control for risk in observational studies of health
outcomes and are now used to adjust for illness in public reports
of hospital mortality.20 21The Centers forMedicare andMedicaid
Services—Hierarchical Condition Categories (HCC) score was
initially developed to adjust payments to health insurers under
the USMedicare Program, but it is also used to adjust mortality
and utilization rates for public reports of health quality and
outcomes research.21 22
The validity of these newer methods of risk adjustment rests on
the assumption that the diagnoses recorded in the administrative
databases accurately reflect the underlying burden of illness in
a region’s population. In other words, these methods assume
that the frequency of diagnosis is independent of intensity of
observation related to a region’s supply of medical care. Several
recent studies have questioned this assumption. The first, a
natural experiment, followed Medicare beneficiaries who
migrated from one region of the United States to another.23
Those who went from a region with low healthcare spending to
one with high spending experienced more visits to physicians,
referrals, diagnostic tests, and imaging exams. Each of these
encounters with the medical system became an opportunity to
identify or code more clinical conditions. Those who migrated
to regions with lower intensity of care acquired fewer diagnoses.
However, mortality rates over a three year follow-up were
similar for migrators regardless of the different rates of “new”
conditions they acquired.
The second, a cross sectional study showed a strong positive
association between the intensity of patient observation, as
measured by visit rates to physicians and the proportion of a
region’s population with a diagnosis of chronic illness.24 This
“observational intensity” effect was not simply the consequence
of poorer health: greater observational intensity led to healthier
people being labeled “chronically ill,” with a commensurate
decline in case fatality rates (the proportion of patients diagnosed
as chronically ill who died). Despite the higher proportion of
the population with a diagnosis of chronic illness, the age, sex,
and race adjusted mortality rates among regions were similar.
The third study evaluated the extent of observational intensity
bias associated with risk adjustment using the standard HCC,
Iezzoni, and Charlson comorbidity indices, and suggested an
approach to reduce this bias.19-25 Application of the standard
indices resulted in implausible changes in adjusted mortality
rates in regions of high and low visits. For example, in regions
with high rates of visits, adding the HCC index to age, sex, and
race adjustment caused a 10% downward swing in adjusted
mortality and an upward swing of over 12% in regions with low
rates of visits. However, the observational intensity biases of
the standard indices could be reduced through a statistical
adjustment to correct for variation in visit rates. The visit
corrected comorbidity indices proved better risk adjusters than
the standard indices: they reduced overall variation in age, sex,
and race adjusted mortality; they also explained more of the
residual variation in age, sex, and race adjusted mortality than
the standard indices.
For the current study we developed two new approaches to risk
adjustment based on data that is clearly independent of
observational intensity. Our first approach used a single measure
of deprivation: the percent of the population below poverty as
defined by the US census. The second approach used a
composite index of population health: self reported illness,
obesity, smoking status, and the regional incidence of admission
to hospital for hip fractures and strokes.We compared the ability
of each approach to reduce the residual variation in age, sex,
and race adjusted mortality and spending per capita across
regions; explain these residual variations; and avoid implausible
swings in mortality and spending rates in regions with high and
low visit rates. We then considered the implications of our study
for risk adjustment in the US and the National Health Service.
Methods
Data
The study population included a 20% sample of Medicare
beneficiaries residing in 306 hospital referral regions in the
United States in 2007, identified from the 2007 Centers for
Medicare and Medicaid Services denominator file.1 Hospital
referral regions were empirically developed based on patient
origin studies to define the geographic region served by tertiary
hospitals. We restricted the analysis to fee for service
beneficiaries who were either fully enrolled in part A and part
B throughout 2007 and who were 65-99 years old on 31
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December 2007, or fully enrolled beginning 1 January 2007
until their death that year and who were 65-99 years old at their
time of death.We excluded beneficiaries enrolled in risk contract
Medicare Advantage plans because their administrative
databases are incomplete. The final sample totaled 5 153 877
beneficiaries.
Mortality and spending adjusted for age, sex,
and race
The numerator for mortality rates was the number of deaths
from any cause in calendar year 2007 among the study
population (based on death dates obtained from the Medicare
denominator file). The numerator for spending rates per capita
was the 2007 price adjusted total reimbursement for this
population. Price adjustment removes reimbursements for
graduate medical education, extra payments made to hospitals
serving low income populations (“disproportionate share”
payments), and differences in wages.26
We used a standard adjustment approach estimated at the
individual level (n=5 153 877). We initially adjusted solely for
age, sex, and race at the level of the individual beneficiary using
linear regression models (SAS GENMOD procedure)
incorporating 20 indicator variables to represent all age, sex,
and race combinations (a logistic regression model yielded
similar results). In addition to the individual level categorical
variables (with means set equal to zero) we included the 306
hospital referral regions as classification variables for regional
effects. We then used the hospital referral region level
coefficient estimates to construct age, sex, and race adjusted
measures of mortality and price adjusted expenditures at the
hospital referral region level.
Mortality and spending adjusted for risk
We compared four approaches to risk adjustment that used
different indices of illness. The first approach used the standard
HCC method. We calculated patient level HCC risk scores,
employing coding algorithms that are used by the Centers for
Medicare and Medicaid Services to adjust payments for
Medicare Advantage plans.27 For each beneficiary we assigned
HCCs using diagnoses coded on their 2007 part A hospital
discharges, part B evaluation and management services, part B
procedures, and visits from the outpatient administrative
databases. The algorithm to compute the HCC score incorporates
administrative database diagnoses at the individual level as well
as age, sex, and disability status.
The second approach corrected the HCC index to reduce
observational intensity bias using the physician visit rate during
the last six months of life as a proxy.25 At the regional level, the
visit rate, whether calculated on an annualized basis or for the
last six months of life, was highly correlated with the risk score,
while uncorrelated with age, sex, and race adjusted mortality.
We calculated the visit corrected HCC index by ordinary least
squares regression analysis in which the dependent variable was
the individual level risk score; the independent variable was
physician visit at the regional level. The residual from this
regression—the difference between the observed and predicted
risk score—is the visit corrected HCC index. It represents the
component of illness that is not explained by frequency of
physician visits.
The third approach to risk adjustment was based solely on
poverty: the percentage of the population aged 65 and over
below the federal poverty level as defined by the US census for
2000. This is measured at the zip code level for black and
non-black Americans and assigned to all beneficiaries according
to their race and zip code of residence.
The fourth approach used data on population health using five
measures. Two of these are annual rates for hip fractures and
strokes at the hospital referral region level, which were
computed for Medicare beneficiaries who were aged 65-99 and
part A entitled in 2006 using the 2006 part A hospital
administrative database for primary diagnosis for hip fracture
and diagnosis related groups for stroke. We computed age, sex,
and race adjusted rates at the hospital referral region level for
two subgroups, the young old (65-79), and the very old (80-99),
and applied to each age group within the hospital referral
regions. The other three were county level measures of obesity,
smoking status, and self reported illness (measured by average
number of poor physical health days per month) from the 2010
Behavioral Risk Factor Surveillance System (BRFSS) (www.
countyhealthrankings.org). These three were selected through
first identifying as candidate variables those measures that are
independent of a physician’s diagnosis (for example, “Now
thinking about your physical health, which includes physical
illness and injury, for how many days during the past 30 days
was your physical health not good?”), and avoiding those that
may be influenced by intensity of observation (for example,
“Have you ever been told by a doctor that you have diabetes?”).
Once the candidate questions were identified we used statistical
power to select the final BRFSS measures to include in our
model. All of these risk adjustors were assigned to individuals
in our study population according to their county of residency;
for a small number of beneficiaries with non-linking county
data, we used a measure at hospital referral region level.
Evaluation
We used standard statistics to describe the variation in age, sex,
and race adjusted mortality rates and age, sex, race, and price
adjusted rates of spending per capita across the 306 hospital
referral regions. The ability of the four risk adjustment indices
to reduce variation in the distribution of the adjusted mortality
and spending rates among the 306 regions was measured by the
interquartile range, the extremal ratio, and the coefficient of
variation. We evaluated their ability to explain variation in
adjusted rates of mortality and spending using the coefficient
of determination (the R2 statistic). We present both weighted
R2 (by hospital referral region population) and unweighted R2
in the figures and tables, but use the weighted measure in the
text. An F test was used to judge whether the predictive
measures were jointly significant at the 5% level. A bootstrap
method was used to calculate confidence limits for the R2
statistic.
Our measure for observational intensity is the average per capita
Medicare physician visit rates (all evaluation and management
services) in the last six months of life at the hospital referral
region level. To ensure that no direct relation could exist
between our proxy for intensity of observation and our outcomes
(mortality or spending) we measured physician visits in the
prior year (2006).We evaluated the effect of adjustment method
on predicted mortality and spending rates in regions with high
and low rates of visits by aggregating hospital referral regions
in fifths of equal population size based on physician visit rates.28
For these estimates, we ran a series of regression models similar
to the regional models but incorporated the fifths as the
classification variable instead of hospital referral region.
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Results
Ability to explain variation in age, sex, and
race adjusted mortality
Figure 1⇓ and table 1⇓ show the distribution and summary
statistics for Medicare mortality rates across the 306 hospital
referral regions using the four risk adjustment indices. The
coefficient of variation from that of age, sex, and race adjustment
alone was 9.7 (the standard deviation was 9.7% of the mean).
This value was lowered 33% to 6.5 for the population health
index, 17% to 8.1 for the visit corrected Hierarchical Condition
Categories (HCC) index, and 7% to 9.1 for the poverty index.
Adjustment using the standard HCCmethod increased variation
in mortality rates by 14% (coefficient of variation=11.0).
Figure 2⇓ shows how well each index explained variation in
age, sex, and race adjusted mortality, using unweighted and
weighted regressions. Using regressions weighted by population,
the standard HCC index explained less than 5% of the residual
variation; the visit corrected HCC index and the poverty index
explained more than three times as much (17% and 19%,
respectively) and the population health index over 10 times as
much (65%).
Ability to explain variation in spending
Age, sex, race, and price adjusted spending per capita in the
20% sample varied among regions from $5323 (£3225; €3851)
to $15 706 (coefficient of variation=15.2, table 2⇓). Adding the
standard HCC index reduced this variation by 36% (coefficient
of variation=9.8), but the visit corrected HCC index and the
indices for poverty and population health had little impact
(coefficient of variation=14.4, 14.8, and 13.9, respectively).
Figure 3⇓ shows the ability of the four indices to explain residual
variation in age, sex, race, and price adjusted spending. In the
weighted regressions, the standard HCC index explained the
most: 45% of the residual variation in age, sex, race, and price
adjusted spending; however, the visit corrected HCC explained
the least (<5%). The poverty and population health indices
explained 12% and 21% of the age, sex, and race adjusted
variation, respectively.
Effects of adjustment in regions with low and
high rates of visits
Table 3⇓ illustrates the effect of risk adjustment on estimated
age, sex, and race adjusted rates of mortality and spending per
capita among hospital referral regions aggregated across fifths
of visit rates (the visit rate in the highest fifth was 2.4 times that
of the lowest fifth). For mortality, adding the standard HCC
index to age, sex, and race risk adjustment increased the
estimated relative mortality by 12.1% in the lowest visit fifth,
and decreased it by 10.5% in the highest fifth. These shifts
resulted in a difference of over 22% in estimated mortality rate
between the highest and lowest fifths. By contrast, the visit
corrected HCC index, poverty, and population health indices
resulted in little change in estimated mortality compared with
age, sex, and race adjustment alone. With the population health
index, the difference in adjusted mortality rates between highest
and lowest visit fifths was less than 1%.
For spending, adding the standard HCC method to age, sex,
race, and price adjustment resulted in large swings in estimated
spending by visit fifth: a relative increase of over 20% in the
lowest fifth, and a relative decrease of 15% spending in the
highest fifth. These large swings were not seen using the visit
corrected HCC, poverty, or the population health indices; they
resulted in only minor changes in estimated spending (−0.8%
to 2.0% in the lowest fifth, and −0.1% to 3.5% in the highest
fifth). Using the visit corrected HCC, poverty, and the population
health indices for adjusting for illness resulted in estimated
spending that was similar to adjustment by age, sex, race, and
price adjustment alone: spending in the highest visit fifth was
33% to 35% greater than in the lowest fifth.
Discussion
Accurate health risk adjustment is critical to the equitable
distribution of resources as more countries allow enrolees to
have choice of insurer or provider. Our prior work showed that
risk adjustment methods using International Classification of
Diseases diagnosis codes recorded in administrative databases
are biased by the strong influence observational intensity has
on the frequency of diagnosis: the more encounters in the
population, the sicker the population seems to be, independent
of underlying burden of illness as measured by the age, sex, and
race adjusted mortality. The current study evaluated two new
approaches to health risk adjustment that do not depend on
diagnoses recorded in administrative databases. One approach
used a single measure of deprivation obtained from the US
census; the second was a composite index of health based on
five measures of population health. The deprivation and the
population health indices performed better than the standard
Hierarchical Condition Categories (HCC) index: they reduced
and explained much more of the variation in age, sex, and race
mortality and did not exhibit an observational intensity bias as
measured by the frequency of physician visits. In contrast, the
standard HCC index explained less than 5% of the variation in
age, sex, and race adjusted mortality, increased rather than
reduced variation, and resulted in implausible swings in
mortality rates in regions with high and low levels of physician
visits per capita.
The standard HCC index explained the most variation in age,
sex, race, and price adjusted regional spending. However, the
purpose of health risk adjustment for expenditures is not to
maximize the explained R2 in spending, but instead to capture
the components of spending that are the consequence of poor
health. The HCC index, created from administrative databases,
may be correlated with spending (almost by construction), but
the fact that it is so poorly associated at the regional level with
mortality casts doubt on its effectiveness in adjustment for health
risk. More importantly, when the standard HCC index was visit
corrected, it accounted for only 5% of the variation in regional
spending. Indeed, once the standard HCC index was corrected
to control for observational intensity bias, both the deprivation
and the population health indices performed better in terms of
ability to explain variation in spending.
The population health index used data from two sources that
were conveniently available for the entire US population. The
Behavioral Risk Factor Surveillance System is an annual survey
representative of the population. We selected only a few of the
questions available on the survey. Our approach was to avoid
those questions that could easily be influenced by the same
observational intensity bias as present in the administrative
databases (such as “Have you been told you have diabetes?”)
and focus on unequivocal measures of population health, such
as obesity, smoking status, and self perception of physical health.
Still, these measures could be expanded to include additional
dimensions of health. We also used two administrative database
measures in our population health index: rates of admission to
hospital for stroke and hip fracture. Prior work has shown that
these “low variation” conditions are less subject to the influence
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of supply factors than other admissions to hospital as they are
both “easy to diagnose” and universally lead to hospital stay.1
Limitations of this study
Several limitations of this study should be considered. Firstly,
because data are unavailable for Medicare Advantage
populations (the managed care plan), our study only includes
beneficiaries in traditionalMedicare. However, the HCCmodels
were developed, and continue to be calibrated, on the traditional
Medicare population. Secondly, we used mortality as a proxy
for overall population health rather than a more subtle measure.
Given the inaccuracy of methods that rely on diagnoses from
administrative databases for adjustingmortality, those interested
in more subtle measures of health may need to find other
approaches. Thirdly, we used county level measures of self
reported illness, obesity, and smoking status rather than patient
level measures. It is possible that patient level data will reveal
different findings than those reported here. This is an empirical
question that can and should be answered.
Implications for equitable distribution of funds
in the United States
The Dartmouth Atlas of Health Care consistently shows more
than a twofold variation in age, sex, and race adjusted spending
among hospital referral regions across the United States. An
important policy finding from our current study is that Medicare
spending continues to show great regional variation when
spending is further adjusted using the best predictors of illness
as measured by mortality. A recent Institute of Medicine study
on regional variations (mandated by the US Congress) found
that adjustment with the standard HCCmethod seemed to reduce
variation in spending.29 Our study showed that the apparent
reductions in regional variations in the Institute of Medicine’s
study are the consequence of a flawed risk adjustment approach
that conflates illness with observational intensity. Furthermore,
since using HCC scores adjusts mortality downward in regions
with high visit rates and upward in low visit regions, regression
analysis using HCC adjustment will always show that higher
intensity of care is associated with better health outcomes.30 31
These biases have become more than an interesting research
finding as the Centers forMedicare andMedicaid Services move
from volume based payments to payments related to risk
adjusted outcomes.32 33
Relevance to other countries
Belgium, the Czech Republic, Germany, Israel, the Netherlands,
Slovakia, and Switzerland have implemented policies that enable
consumers’ periodic choice between insurers. Van de Ven34
pointed out that without effective regulation, competition
between insurers creates incentives for them to attract people
with low additional risk (“cream skimming”) and deter those
with high risk (“adverse selection”). He argues that a system of
risk equalization that reallocates resources between insurers
according to the risk of their populations is critical to effective
regulation. A system of risk equalization, in turn, requires
adequate measures of additional risk at the level of the
individual. As van de Ven pointed out, countries implementing
choice between insurers typically had “poor to moderate”
systems of risk equalization. The “most sophisticated risk
adjustment formulas” van de Ven identified were the US
Medicare program and the Netherlands statutory health
insurance scheme. Both use methods that rely on data from
administrative databases that can be noticeably improved by
use of more accurate risk adjustment models that are not subject
to observational intensity bias.
In England, patients in effect choose a local insurer, a clinical
commissioning group (CCG), through choice of a general
practitioner. To support allocation of funds across CCGs, the
NHS has developed measures of health risk at the level of the
individual, which include diagnoses from administrative
data.17 18Our study suggests that these will be inadequate to
prevent “cream skimming” and “adverse selection,” and will
ultimately jeopardize equitable distribution of healthcare
resources. We recommend research to determine whether
observational intensity bias applies in England and other
countries, and whether health risk would be better estimated
from data on poverty and morbidity.
Conclusion
Our studies point to the need for measures of health and
morbidity independent of administrative database diagnoses.
The new measures must be free of observational intensity, and
they must efficiently and effectively assess population health
when adjusting mortality and spending. Where might these
measures come from? In the United States the Affordable Care
Act contains provisions to pay for an annual survey to capture
patient reported data. As envisioned in the Affordable Care Act,
these data will primarily be used to assess patient experience,
a critical outcomes measure for value based care. Our study
suggests a “twofer” for this annual survey: it creates an
opportunity for a national strategy to develop patient level
population health measures for use in risk adjustment. Such
measures would be useful to several federally sponsored
interventions that require risk adjustment, such as payment
under the Medicare Advantage program, shared savings under
the Accountable Care Organization provision, payment
withholds under programs to reduce readmissions, and premium
adjustments under insurance exchanges. The data would also
serve to support risk adjustment in observational studies of
health outcomes, much of which is funded by federal agencies
and the Patient-Centered Outcomes Research Institute
established under the Affordable Care Act. Finally, in other
countries where patients have a choice between providers or
insurers, an adequate method of health risk adjustment is critical
for equitable distribution of resources. Our findings suggest that
these methods would be better estimated using data on health,
and points to several candidate measures, including hip fracture
and stroke rates, self reported health status, smoking, and
obesity.
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What is already known on this topic
Illness adjustment methods using routinely recorded diagnoses are subject to bias associated with medical supply: populations with
higher visit rates to physicians have more diagnoses and therefore seem to be sicker
The bias is substantial; use of these methods results in the mortality in regions in the highest fifth of visit rates that were 12.5% lower
than the regions in the lowest fifth
When the US Medicare’s risk adjustment method was corrected to remove the effect of visit rates, mortality rates were similar in the
highest and lowest fifths
What this study adds
Two indices to health risk adjustment independent of physician diagnosis were evaluated: deprivation and five population health
measures—smoking status, obesity, self reported illness, hip fracture, and admissions for stroke
Both indices explained more of the variation in age, sex, and race adjusted mortality rates than Medicare’s diagnoses based method,
with the population health index explaining 65% of the variation
Once Medicare’s diagnoses based method was adjusted for visit rates it did a poor job of explaining variation in regional spending, the
population health index explained the most
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Tables
Table 1| Descriptive statistics of the effect of four risk adjustment indices on variation in Medicare mortality rates per 1000 population in
2007 across 306 hospital referral regions
ASR population health
adjusted mortality
ASR poverty adjusted
mortality
ASRHCC visit corrected
mortality
ASR HCC adjusted
mortality
ASR adjusted
mortalityStatistics
52.3 (50.2-54.3)52.7 (49.3-55.6)52.2 (50.1-55.0)54.5 (50.1-57.7)52.9 (49.4-55.9)Median (interquartile range)
52.352.552.353.752.7Mean
6.59.18.111.09.7Coefficient of variation
1.701.521.592.241.77Extremal ratio
−32.5−6.5−16.713.9—Coefficient of variation %
change from ASR
ASR=age, sex, and race; HCC=Hierarchical Condition Categories.
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Table 2| Descriptive statistics of the effect of four risk adjustment indices on variation in Medicare spending per beneficiary in 2007 across
306 hospital referral regions
ASR price population
health adjusted spending
ASR price poverty
spending
ASR price HCC visit
corrected spending
ASR price HCC
adjusted spending
ASR price adjusted
spendingStatistics
8168 (7444-8930)8208 (7268-8983)8075 (7461-8999)8409 (7915-8941)8276 (7366-9053)Median (interquartile range)
82678236824984628305Mean
13.914.814.49.815.2Coefficient of variation
2.992.722.491.932.95Extremal ratio
−8.9−3.2−5.7−36.0—Coefficient of variation %
change from ASR
ASR=age, sex, and race; HCC=Hierarchical Condition Categories.
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Table 3| Effect on apparent mortality and Medicare spending of four methods of risk adjustment in regions ranked into fifths according to
mean number of physician visits in last six months of life
Ratio
highest to
lowest fifth
Fifths of visits (95% CI), % change*
Variables 5th (highest)4th3rd2nd1st (lowest)
2.4343.931.226.823.618.0Visits per decedent
Effect on mortality:
0.9850.0 (49.5 to 50.4)53.1 (52.7 to 53.5)53.1 (52.7 to53.6)54.0 (53.6 to 54.4)51.0 (50.6 to 51.4)ASR adjustment only
0.7844.7 (44.3 to 45.1),
−10.5
51.2 (50.8 to 51.6),
−3.6
53.1 (52.7 to 53.5),
−0.1
55.3 (54.9 to 55.6), 2.457.2 (56.8 to 57.6), 12.1ASR HCC adjustment
1.0152.2 (51.8 to 52.6), 4.552.4 (52.0 to 52.8),
−1.4
52.1 (51.7 to 52.5),
−2.0
52.6 (52.2 to 53.0),
−2.5
51.8 (51.4 to 52.2), 1.5ASR visit corrected HCC
adjustment
0.9950.4 (49.9 to 50.8), 0.853.3 (52.8 to 53.7), 0.253.2 (52.8 to 53.7), 0.253.7 (53.3 to 54.2),
−0.5
50.8 (50.4 to 51.3), −0.4ASR poverty adjustment
1.0152.4 (51.9 to 52.8), 4.952.6 (52.2 to 53.0),
−1.0
51.9 (51.5 to 52.4),
−2.3
52.1 (51.6 to 52.5),
−3.5
52.1 (51.6 to 52.5), 2.1ASR population health
adjustment
Effect on spending:
1.32$9572 (9539 to 9605)$8878 (8844 to 8912)$8498 (8464 to 8531)$8227 (8193 to 8260)$7228 (7195 to 7262)ASR price adjustment
only
1.08$8782 (8759 to 8805),
-8.3
$8595 (8571 to 8619),
-3.2
$8492 (8468 to 8516),
-0.1
$8419 (8395 to 8443),
2.3
$8153 (8129 to 8177),
12.8
ASR price HCC
adjustment
1.359910 (9886 to 9933),
3.5
$8767 (8743 to 87891),
−1.3
$8337 (8314 to 8361),
−1.9
$8027 (8003 to 8051),
−2.4
$7342 (7318 to 7366),
1.6
ASR price visit corrected
HCC
1.33$9565 (9532 to 9598),
−0.1
$8851 (8817 to 8885),
−0.3
$8464 (8430 to 8498),
−0.4
$8144 (8111 to 8178),
−1.0
$7172 (7138 to 7206),
−0.8
ASR price poverty
1.33$9837 (9802 to 9872),
2.8
$8819 (8785-8853),
−0.7
$8341 (8307 to 8375),
−1.8
$8019 (7985 to 8053),
−2.5
$7372 (7337 to 7407),
2.0
ASR price population
health adjustment
$1.00 (£0.60; €0.72).
ASR=age, sex, and race; HCC=Hierarchical Condition Categories.
*Percent change from ASR adjusted mortality or spending.
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Figures
Fig 1 Distribution plots of 2007 mortality rates per 1000 Medicare beneficiaries in each of 306 hospital referral regions for
age, sex, and race (ASR) alone, ASR HCC (Hierarchical Condition Categories), ASR visit corrected HCC, ASR poverty,
and ASR population health
Fig 2 Ability to explain residual variation in age, sex, and race (ASR) adjusted hospital referral regions mortality using four
methods of risk adjustment (R2 statistics and 95% confidence interval; unweighted and weighted). HCC=Hierarchical
Condition Categories
Fig 3 Ability to explain residual variation in age, sex, race (ASR), and price adjusted hospital referral regions spending
using four methods of risk adjustment (R2 statistics and 95% confidence interval; unweighted and weighted). HCC=Hierarchical
Condition Categories
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